LYNX CAPITAL GROUP LTD /ADV’s Johnson & Johnson JNJ Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.28M	Buy	+14,569	New	+$2.23M	1.66%	27

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LYNX CAPITAL GROUP LTD /ADV's JNJ Position: Q4 2023 in Review

LYNX CAPITAL GROUP LTD /ADV opened a new position in Johnson & Johnson (JNJ) in Q4 2023: 14,569 shares worth $2.28M. The stake represents 1.66% of the portfolio and ranks #27 among its holdings.

3,871 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

LYNX CAPITAL GROUP LTD /ADV held 14,569 shares of Johnson & Johnson worth $2.28M as of Q4 2023.
Johnson & Johnson was a new LYNX CAPITAL GROUP LTD /ADV position in Q4 2023.
Johnson & Johnson made up 1.66% of LYNX CAPITAL GROUP LTD /ADV's portfolio in Q4 2023, its #27 holding.
3,871 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2023, filed 7 Aug 2026.